Old Web
English
Sign In
Acemap
>
authorDetail
>
Y Labeaga Beramendi
Y Labeaga Beramendi
American Pharmacists Association
Medicine
Pharmacovigilance
Population
Pediatrics
Factor IX inhibitor
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
2SPD-027 Economic impact of drug shortages
2020
European Journal of Hospital Pharmacy-Science and Practice
C Aparicio-Carreño
Y Labeaga Beramendi
B. Rodríguez
B. Fernandez Gonzalez
A Gándara Ande
FJ Barbazán-Vázquez
C Martinez-Mugica Barbosa
C. Durán Román
Show All
Source
Cite
Save
Citations (0)
4CPS-076 Evaluation of the treatment and morbimortality of infectious endocarditis by staphylococcus aureus
2018
European Journal of Hospital Pharmacy-Science and Practice
Y Labeaga Beramendi
R. Pampin
A León Barbosa
C Durán Romá
A Lozano Blázquez
M Carbajales Álvarez
B. González de Castro
A Ayastuy Ruiz
Show All
Source
Cite
Save
Citations (0)
CP-079 Factor IX inhibitor development in congenital haemophilia b patients with nonacog alfa treatment
2017
European Journal of Hospital Pharmacy-Science and Practice
P Pena Villanueva
S. Suárez Ordóñez
L Macía Fuentes
R Pampín Sánchez
Y Labeaga Beramendi
B Rodríguez de Castro
A León Barbosa
Ai García Rogada
Rm Núñez Rodríguez-Arango
J Ruíz Salazar
Show All
Source
Cite
Save
Citations (0)
CP-138 Spironolactone in paediatrics. toxicity update
2017
European Journal of Hospital Pharmacy-Science and Practice
P Pena Villanueva
J Ruíz Salazar
Rm Núñez Rodríguez-Arango
Ai García Rogada
L Macía Fuentes
A León Barbosa
R Pampín Sánchez
Y Labeaga Beramendi
B Rodríguez de Castro
A Rodriguez Palomo
Show All
Source
Cite
Save
Citations (0)
1